Angioshield First-In-Human Study to Demonstrate the Preliminary Safety and Efficacy

NCT02072239 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: Angioshield

Sponsor

Neograft Technologies, Incorporated